Andrew M. Anisfeld
- Oncology top 2%
- Surgery top 5%
- Molecular Biology
- Pharmacology top 1%
- Epidemiology top 10%
- Co-authors
- Peter A. EdwardsHeidi R. Kast-WoelbernStacey A. JonesTimothy M. WillsonBryan GoodwinPaul T. TarrPeter TontonozPuiying A. Mak
- Topics
- Drug Transport and Resistance Mechanisms (7 papers)Cholesterol and Lipid Metabolism (4 papers)Rheumatoid Arthritis Research and Therapies (3 papers)
- Cited by
- PharmacologyOncologySurgery
- Partner nations
- United StatesNetherlandsSwitzerland
In The Last Decade
Andrew M. Anisfeld
10 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Oncology 1.0k
- Surgery 684
- Molecular Biology 542
- Pharmacology 391
- Epidemiology 261
Countries citing papers authored by Andrew M. Anisfeld
This map shows the geographic impact of Andrew M. Anisfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew M. Anisfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew M. Anisfeld more than expected).
Fields of papers citing papers by Andrew M. Anisfeld
This network shows the impact of papers produced by Andrew M. Anisfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew M. Anisfeld. The network helps show where Andrew M. Anisfeld may publish in the future.
Co-authorship network of co-authors of Andrew M. Anisfeld
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew M. Anisfeld. A scholar is included among the top collaborators of Andrew M. Anisfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew M. Anisfeld. Andrew M. Anisfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 6 | |
| 3 | 17 | |
| 4 | 33 | |
| 5 | 310 | |
| 6 | 74 | |
| 7 | Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptorbreakdown → | 723 |
| 8 | 106 | |
| 9 | 323 | |
| 10 | 46 |
About Andrew M. Anisfeld
Andrew M. Anisfeld is a scholar working on Hematology, Oncology and Rheumatology, having authored 10 papers that have together received 1.6k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Cholesterol and Lipid Metabolism (4 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). The work is most often cited by research in Pharmacology (391 citations), Oncology (1.0k citations) and Surgery (684 citations). Andrew M. Anisfeld has collaborated with scholars based in United States, Netherlands and Switzerland. Frequent co-authors include Peter A. Edwards, Heidi R. Kast-Woelbern, Stacey A. Jones, Timothy M. Willson, Bryan Goodwin, Paul T. Tarr, Peter Tontonoz, Puiying A. Mak, Anthony J. Roecker and Mark A. Verdecia. Their work appears in journals such as Journal of Biological Chemistry, Molecular Cell and Journal of Lipid Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.